StonvexLoading…
StonvexStonvexStonvexCore line items from WSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-01 | Q4 2025 2025-11-02 | Q3 2025 2025-08-03 | Q2 2025 2025-05-04 |
|---|---|---|---|---|
Revenue | $7.81B | $5.45B | $3.57B | $1.73B |
Operating Income | $1.42B | $937.91M | $618.77M | $290.71M |
Net Income | $1.09B | $720.42M | $247.56M | $231.26M |
EPS (Diluted) | $8.84 | $5.82 | $3.86 | $1.85 |
Total Assets | $5.41B | $5.31B | $5.23B | $5.16B |
Total Liabilities | $3.33B | $3.24B | $3.08B | $3.00B |
Cash & Equivalents | $1.02B | $884.66M | $985.82M | $1.05B |
Free Cash Flow OCF − CapEx | $1.06B | $539.46M | $291.38M | $60.70M |
Shares Outstanding | 118.77M | 120.40M | 121.79M | 122.99M |